Results 81 to 90 of about 33,513 (195)

Influence of losartan on the hypoglycemic activity of glimepiride in normal and diabetic rats

Therapeutic Advances in Endocrinology and Metabolism, 2013
Background: The influence of losartan on the hypoglycemic effect of glimepiride was studied in normal and diabetic rats. Method: Losartan and glimepiride were studied at a dose of 4.5 and 0.09 mg/kg and in normal and diabetic rats, respectively.
T.E.G.K. Murthy, Manogna K. Kommineni, Candasamy Mayuren   +2 more
doaj   +1 more source

Combination of Losartan and Platinum Nanoparticles with Photothermal Therapy Induces Immunogenic Cell Death Effective Against Neuroblastoma [PDF]

Xiaojun Zhang,1,* Ying Zhao,2,* Zhaogang Teng,3 Tangyao Sun,3 Jun Tao,3 Jiang Wu,4 Yu Wang,3 Fan Qiu,4 Feng Wang4 1Department of Radiology, Children’s Hospital of Nanjing Medical University, Nanjing, 210018, People’s Republic of China ...
Tao J, Wu J, Qiu F, Zhang X, Sun T, Wang F, Wang Y, Teng Z, Zhao Y   +8 more
core  

Losartan therapy in gout patients [PDF]

, 2008
Aim. To study losartan effectiveness and safety in patients with gout and arterial hypertension (AH).Material and methods. In total, 30 patients not having goat attack were examined (mean age 49,8+10,5 years, disease duration - 6,5 (3,0;16) years). For 8
A. I. Ilyina, B. G. Barskova, E. L. Nasonov   +2 more
core  

Framework for headache management in pediatric patients with stroke and cerebrovascular lesions: A narrative review

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To present a practical, evidence‐based framework for the management of headache disorders in pediatric patients with prior stroke or underlying cerebral vascular lesions, with particular attention to safety and efficacy of pharmacologic and non‐pharmacologic therapies.
Allison C. Hyland, Samuel J. Belfer, Christine K. Fox, Samantha L. Irwin, Rachel Vassar, Ann Oh, Sruthi Ilangovan, Amy A. Gelfand   +7 more
wiley   +1 more source

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension

, 2012
Ola Granström,1 Lars-Åke Levin,2 Martin Henriksson11AstraZeneca Nordic, Södertälje, 2Center for Medical Technology Assessment, Linköping University, Linköping, SwedenBackground: Although angiotensin ...
Levin LA, Granström O, Henriksson M   +2 more
core  

Water‐Dispersible Ruthenium Nanocatalyst for Carbonyl Reduction With D2 or T2 in Aqueous Media

Angewandte Chemie, Volume 138, Issue 38, 14 September 2026.
We report the synthesis and characterization of water‐dispersible ruthenium nanoparticles that catalyze the reductive deuteration and tritiation of carbonyl compounds in aqueous media, enabling efficient access to a broad range of isotopically labeled polar molecules, including cyclic peptides, antibody‐drug conjugate linkers, pegylated derivatives ...
Elisa Martinelli, Rafael Jiménez Rioboo, Remo Weck, Sophie Feuillastre, Luis M. Martínez‐Prieto, Grégory Pieters, Volker Derdau   +6 more
wiley   +2 more sources

Effects of esaxerenone add‐on therapy versus angiotensin II receptor blocker dose escalation on albuminuria and blood pressure in hypertensive patients with type 2 diabetes: An exploratory randomized study

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Aims Residual albuminuria remains a major clinical challenge in patients with type 2 diabetes mellitus and hypertension despite renin–angiotensin system inhibitor therapy. Esaxerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, reduces albuminuria; however, its effects on oxidative stress remain unclear.
Makoto Ohara, Takemasa Omachi, Nobuaki Takehana, Tomoki Fujikawa, Naoya Osaka, Shunichiro Irie, Michishige Terasaki, Yusaku Mori, Takanori Matsui, Sho‐ichi Yamagishi   +9 more
wiley   +1 more source

Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials

Cardiology and Therapy, 2019
Introduction The role of losartan in preventing aortic root dilatation in Marfan syndrome has been evaluated in many clinical trials; however, the results are conflicting.
Ayman Elbadawi, Mohamed A. Omer, Islam Y. Elgendy, Ahmed Abuzaid, Ahmed H. Mohamed, Devesh Rai, Marwan Saad, Amgad Mentias, Ahmed Rezq, Diaa Kamal, Wissam Khalife, Barry London, Mohamed Morsy   +12 more
doaj   +1 more source

Sleep characteristics and self‐reported sleep quality in the oldest‐old: Results from a prospective longitudinal cohort study

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Little is known about the correlation between subjective perception and objective measures of sleep quality in particular in the oldest‐old. The aim of this study was to perform longitudinal home sleep monitoring in this age group, and to correlate results with self‐reported sleep quality.
Hugo Saner, Kevin Möri, Narayan Schütz, Philipp Buluschek, Tobias Nef   +4 more
wiley   +1 more source

Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial

, 2013
GD Radchenko, YM Sirenko, SM Kushnir, OO Torbas, AS DobrokhodSecondary Hypertension Department, National Scientific Center, Strazhesko Institute of Cardiology, Kiev, UkraineBackground: The aim of this study was to compare the antihypertensive efficacy of
Torbas OO, Sirenko YM, Dobrokhod AS, Radchenko GD, Kushnir SM   +4 more
core